In addition, PITX2 enhanced the ABC drug resistance of colon cancer cells via inversely regulating the human OCT3 (gene, Slc22a3) protein and ATP-binding cassette drug transporters [25]. The gene discussed is SLC22A3; the disease is malignant colon neoplasm.